Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01990131 · ClinicalTrials.gov registry record · NA

Computerized Anxiety Treatment for Suicide

A NA study of Anxiety and Suicide, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
74
Enrollment target
1
Study location

NCT01990131 is a NA study of Anxiety and Suicide that has completed, run by Florida State University. The registered enrollment target is 74 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01990131, a NA study of Anxiety and Suicide, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the effectiveness and usability of multiple computer-based treatments for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with a variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal ideation, and substance use disorders.

Conditions Studied

Interventions

  • OTHER Cognitive Anxiety Sensitivity Treatment
  • OTHER Physical Health Education Training

Study Locations (1)

Florida

  • Anxiety and Behavioral Health Clinic - Tallahassee

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2013-10
Est. Completion 2016-07
Phase NA

Sponsor

Florida State University

219 total trials

What the Registry Record Tells You About NCT01990131

The ClinicalTrials.gov registry entry for NCT01990131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (83% lower). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Anxiety Sensitivity Treatment is the first listed.

NCT01990131 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01990131 about?

NCT01990131 is a clinical study titled "Computerized Anxiety Treatment for Suicide". The purpose of this study is to test the effectiveness and usability of multiple computer-based treatments for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with a variety of negative mental health outcomes s...

What is the current status of trial NCT01990131?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2013-10. Estimated completion is 2016-07.

What conditions does trial NCT01990131 study?

This clinical trial studies the following conditions: Anxiety, Suicide.

What interventions are being tested in trial NCT01990131?

The interventions under investigation include: Cognitive Anxiety Sensitivity Treatment (OTHER), Physical Health Education Training (OTHER).

Who is sponsoring clinical trial NCT01990131?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01990131 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.